@MandalaMario profile picture
Mario Mandala @MandalaMario

Associate professor of Medical Oncology

Joined December 2012
  • Tweets 222
  • Following 289
  • Followers 287
8 Photos and videos
Just published our manuscript on discontinuation of combo immunotherapy in melanoma patients with brain metastases jitc.bmj.com/content/14/5/e0…

Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases

Background Nivolumab plus ipilimumab (COMBO) is the standard treatment for asymptomatic melanoma brain metastases (MBM), but current guidelines do not provide specific recommendations for treatment...

jitc.bmj.com
4
72
Mario Mandala retweeted
Hussein Tawbi, MD, PhD
@HTawbi_MDPhD
Apr 24
Comprehensive overview of systemic therapy for Melanoma Brain Mets by @MandalaMario #EADO2026, first question by the audience highlights the uncertainties in defining “symptomatic” brain metastases
2
9
775
Mario Mandala retweeted
OncoDaily
@oncodaily
Feb 24
Updated EORTC Protocol for Sentinel Lymph Node Evaluation in Merkel Cell Carcinoma - Mario Mandalà @EORTC @MandalaMario oncodaily.com/voices/mario-m… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedTwitter
1
3
91
Mario Mandala retweeted
Piotr Rutkowski@rutkowskip1972
Feb 21
melanoma.viamedica.pl/56498.… in less then one month unique webinar @MandalaMario @OnkologiaPolska @NIO_PIB #melanoma #skincancer

Advances in diagnostics and therapy of melanoma and other skin cancers 2026 - Virtual Meeting 1 |...

melanoma.viamedica.pl
1
2
94
Mario Mandala retweeted
Via Medica@ViaMedica_pl
31 Dec 2025
📢 „Advances in diagnostics and therapy of melanoma and other skin cancers” 📅 19 marca i 14 maja 2026 Zapraszają: prof. dr hab. n. med. Piotr Rutkowski, prof. Mario Mandalà 🤝 Patronat: Akademia Czerniaka, IMI Bezpłatna rejestracja: melanoma.viamedica.pl #melanoma #oncology
1
3
4
232
Mario Mandala retweeted
Andrea Boutros@boutrosand
19 Oct 2025
Amazing discussion about #irAEs #ESMO25 by super @MandalaMario & fantastic @DrJNaidoo early this morning - check it out online on the @myESMO website if you missed it - 👏🏽👏🏽🇮🇹 @ImiItaliano
4
17
1,058
Super interesting, interactive, outstanding meeting on rare toxicities in patients receiving Immunotherapy A special thant to @DrJNaidoo Jarushka Naidoo for charing the session Thanks @myESMO for organising such beautiful and engaging meeting
2
206
Statins to prevent anthracycline-related myocardial toxicity: The jury is still out - PubMed pubmed.ncbi.nlm.nih.gov/3885…

Statins to prevent anthracycline-related myocardial toxicity: The jury is still out - PubMed

Statins to prevent anthracycline-related myocardial toxicity: The jury is still out

pubmed.ncbi.nlm.nih.gov
1
53
Incidence and prognosis of cutaneous melanoma in European adolescents and young adults (AYAs): EUROCARE-6 retrospective cohort results - PubMed pubmed.ncbi.nlm.nih.gov/3954…

Incidence and prognosis of cutaneous melanoma in European adolescents and young adults (AYAs):...

Differences in IR between males and females may be due to different behaviors and CM biology. The increase in survival can be attributed to healthcare improvements, early diagnosis, and locoregional...

pubmed.ncbi.nlm.nih.gov
52
European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics - Update 2024 - PubMed pubmed.ncbi.nlm.nih.gov/3970…

European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics - Update...

This guideline was developed in close collaboration with multidisciplinary experts from the European Association of Dermato-Oncology (EADO), the European Dermatology Forum (EDF) and the European...

pubmed.ncbi.nlm.nih.gov
40
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2024 - PubMed pubmed.ncbi.nlm.nih.gov/3970…

European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2024...

A unique collaboration of multi-disciplinary experts from the European Association of Dermato-Oncology (EADO), the European Dermatology Forum (EDF), and the European Organization of Research and...

pubmed.ncbi.nlm.nih.gov
2
26
Immunotherapy or targeted therapy with or without stereotactic radiosurgery for patients with brain metastases from melanoma or non-small cell lung cancer - The ETOP 19-21 USZ-STRIKE study - PubMed pubmed.ncbi.nlm.nih.gov/3973…

Immunotherapy or targeted therapy with or without stereotactic radiosurgery for patients with brain...

Immunotherapy or targeted therapy with or without stereotactic radiosurgery for patients with brain metastases from melanoma or non-small cell lung cancer - The ETOP 19-21 USZ-STRIKE study

pubmed.ncbi.nlm.nih.gov
32
Clinical validation of droplet digital PCR assays in detecting BRAFV600-mutant circulating tumour DNA as a prognostic biomarker in patients with resected stage III melanoma receiving adjuvant therapy (COMBI-AD): a biomarker analysis from a randomised study pubmed.ncbi.nlm.nih.gov/4025…

Clinical validation of droplet digital PCR assays in detecting BRAFV600-mutant circulating tumour...

Novartis.

pubmed.ncbi.nlm.nih.gov
32
Mario Mandala retweeted
Via Medica@ViaMedica_pl
16 Jul 2025
📢 Warsaw Skin Cancer Conference 2025 📅 3–4.10.2025 | 📍 Warszawa Pod kierunkiem prof. Piotra Rutkowskiego o czerniaku, nowych terapiach i wyzwaniach w leczeniu nowotworów skóry 👉 wsc.viamedica.pl/ #melanoma #onkologia #WarsawSkinCancer2025
6
9
1,310
Mario Mandala retweeted
Fondazione Aiom@AiomFondazione
11 Jul 2025
Martedì 15 luglio alle 17 vi aspettiamo su #AIOMtv per parlare di eccessiva esposizione al #sole e #prevenzione. Link alla diretta: youtube.com/live/abszi3p4HMQ #fondazioneaiom #oncologia #cancro
1
2
94
Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: an international retrospective study - European Journal of Cancer ejcancer.com/article/S0959-8…

Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant...

Ipilimumab plus nivolumab (COMBO) is the standard treatment in patients with asymptomatic melanoma brain metastases (MBM). We report a retrospective study aiming to assess the outcome of patients...

ejcancer.com
1
1
3
252
Mario Mandala retweeted
Piotr Rutkowski@rutkowskip1972
15 Feb 2025
melanoma.viamedica.pl/47861.… join us for Virtual Meetings on Skin Cancers #melanoma @MandalaMario @NIO_PIB @OnkologiaPolska 6 March and 22 May
1
6
254
Adjuvant pembrolizumab did not have a significant impact on long-term HRQOL compared with placebo in patients with resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): long-term, health-related quality-of-life results thelancet.com/journals/lanon…

1
2
131
Understanding timing of SRS and immunotherapy: the right study for the right question in patients with brain metastases from melanoma or non-small cell lung cancer – The ETOP 19-21 USZ-STRIKE study - Lung Cancer lungcancerjournal.info/artic…

Immunotherapy or targeted therapy with or without stereotactic radiosurgery for patients with brain...

Brain metastases may affect up to 30 % of patients with metastatic cancer and are a major cause for morbidity and mortality. Treatment approaches include neurosurgery, various approaches of radioth...

lungcancerjournal.info
2
2
10
405
Mario Mandala retweeted
Piotr Rutkowski@rutkowskip1972
31 Oct 2024
dermato-oncology2024.com/pro… very interesting conference on dermatooncology in Vienna. Proud to be part of faculty. Congratulations for @MandalaMario and Lex Eggermont @OnkologiaPolska @NIO_PIB
1
8
259
Load more